CXCL6 antibody neutralization prevents lung inflammation and fibrosis in mice in the bleomycin model (scientific article published on 23 August 2013)

Cyclooxygenase-2-dependent expression of angiogenic CXC chemokines ENA-78/CXC Ligand (CXCL) 5 and interleukin-8/CXCL8 in human non-small cell lung cancer

Q40583103

Role of the chemokine receptor CXCR2 in bleomycin-induced pulmonary inflammation and fibrosis

Q42442718

Expression of functional toll-like receptor-2 and -4 on alveolar epithelial cells.

Q42459176

Tissue inhibitor of metalloproteinase-1 deficiency amplifies acute lung injury in bleomycin-exposed mice

Q42575229

Extracellular ATP is a danger signal activating P2X7 receptor in lung inflammation and fibrosis

Q43044973

Cytokine profile of bronchoalveolar lavage fluid in patients with combined pulmonary fibrosis and emphysema

Q44285852

ENA-78 is an important angiogenic factor in idiopathic pulmonary fibrosis

Q46319754

Murine CXCR1 is a functional receptor for GCP-2/CXCL6 and interleukin-8/CXCL8.

Q46976911

Protective role of IFN-gamma in collagen-induced arthritis conferred by inhibition of mycobacteria-induced granulocyte chemotactic protein-2 production.

Q52575972

Differential usage of the CXC chemokine receptors 1 and 2 by interleukin-8, granulocyte chemotactic protein-2 and epithelial-cell-derived neutrophil attractant-78

Q28278512

Pulmonary fibrosis: pathogenesis, etiology and regulation

Q28388425

Induction of CXCL5 during inflammation in the rodent lung involves activation of alveolar epithelium

Q28570741

CXCL5 regulates chemokine scavenging and pulmonary host defense to bacterial infection

Q28589805

Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators

Q29615694

Neutrophils in the activation and regulation of innate and adaptive immunity

Q29620082

Critical role of endothelial CXCR2 in LPS-induced neutrophil migration into the lung

Q30439575

Duffy antigen receptor for chemokines and CXCL5 are essential for the recruitment of neutrophils in a multicellular model of rheumatoid arthritis synovium

Q33652016

Integrating mechanisms of pulmonary fibrosis

Q35106452

Amine-reactive OVA multimers for auto-vaccination against cytokines and other mediators: perspectives illustrated for GCP-2 in L. major infection

Q35168395

Oxidative stress and airway inflammation in severe exacerbations of COPD.

Q35537579

Essential roles of the CC chemokine ligand 3-CC chemokine receptor 5 axis in bleomycin-induced pulmonary fibrosis through regulation of macrophage and fibrocyte infiltration.

Q35781428

Role of CXCL5 in leukocyte recruitment to the lungs during secondhand smoke exposure

Q36110564

Matrix metalloproteinases in asthma and COPD.

Q36134365

Bronchial mucosal inflammation and upregulation of CXC chemoattractants and receptors in severe exacerbations of asthma

Q36225732

Neutrophils cascading their way to inflammation

Q36315860

Pathophysiology of exacerbations of chronic obstructive pulmonary disease

Q36458964

Chemokine/cytokine cocktail in idiopathic pulmonary fibrosis

Q36493970

Glucocorticoid-attenuated response genes encode intercellular mediators, including a new C-X-C chemokine

Q36688455

Murine models of pulmonary fibrosis.

Q36997546

The evolution of mammalian chemokine genes.

Q37740571

Inflammasome-IL-1-Th17 response in allergic lung inflammation

Q37965499

Topical antisense oligonucleotide therapy against LIX, an enterocyte-expressed CXC chemokine, reduces murine colitis.

Q40385488

P433

issue

P921

main subject

antibody

Q79460

P304

page(s)

1317-1323

P577

publication date

2013-08-23

P1433

published in

Journal of Leukocyte Biology

Q1524048

P1476

title

CXCL6 antibody neutralization prevents lung inflammation and fibrosis in mice in the bleomycin model

P478

volume

Reverse relations

cites work (P2860)

Q35758535	CD8+ T Cell Response to Gammaherpesvirus Infection Mediates Inflammation and Fibrosis in Interferon Gamma Receptor-Deficient Mice
Q64055054	CXCL6 Promotes Renal Interstitial Fibrosis in Diabetic Nephropathy by Activating JAK/STAT3 Signaling Pathway
Q58779664	CXCL6-EGFR-induced Kupffer cells secrete TGF-β1 promoting hepatic stellate cell activation via the SMAD2/BRD4/C-MYC/EZH2 pathway in liver fibrosis
Q89964203	Editorial: Innovative Biologics and Drugs to Target Renal Inflammation
Q34711894	Ets homologous factor regulates pathways controlling response to injury in airway epithelial cells
Q40544331	Genome-wide association studies identify susceptibility loci affecting respiratory disease in Chinese Erhualian pigs under natural conditions
Q107377157	Identification of key signaling pathways induced by SARS-CoV2 that underlie thrombosis and vascular injury in COVID-19 patients
Q35903156	Lung Infection by Human Bocavirus Induces the Release of Profibrotic Mediator Cytokines In Vivo and In Vitro
Q47655196	MicroRNA Signature of Cigarette Smoking and Evidence for a Putative Causal Role of MicroRNAs in Smoking-Related Inflammation and Target Organ Damage.
Q38744738	MnTBAP Inhibits Bleomycin-Induced Pulmonary Fibrosis by Regulating VEGF and Wnt Signaling
Q35571108	NMDA Receptor Antagonist Attenuates Bleomycin-Induced Acute Lung Injury
Q27321863	Prostatic inflammation induces fibrosis in a mouse model of chronic bacterial infection
Q41160324	Relationships among injury, fibrosis, and time in human kidney transplants.
Q38181073	The epithelium in idiopathic pulmonary fibrosis: breaking the barrier
Q41213879	The neutrophil-recruiting chemokine GCP-2/CXCL6 is expressed in cystic fibrosis airways and retains its functional properties after binding to extracellular DNA.
Q89789591	The secretome profiling of a pediatric airway epithelium infected with hRSV identified aberrant apical/basolateral trafficking and novel immune modulating (CXCL6, CXCL16, CSF3) and antiviral (CEACAM1) proteins
Q35196311	Tumor necrosis factor: a mechanistic link between angiotensin-II-induced cardiac inflammation and fibrosis.
Q36865803	Vaccinia vaccine-based immunotherapy arrests and reverses established pulmonary fibrosis.